Zobrazeno 1 - 10
of 7 811
pro vyhledávání: '"negative syndrome"'
Autor:
Sumaila Asif, Jigyansa Ipsita Pattnaik, Ipsita Debata, Sudipta Kumar Das, Jayaprakash Russell Ravan, Swayanka Samantaray, Ramakant Swain
Publikováno v:
Archives of Mental Health, Vol 25, Iss 2, Pp 102-106 (2024)
Context: Although neuroleptics are available for treating schizophrenia, patient compliance with treatment remains a major hurdle. Such patients turn into treatment-resistant schizophrenia (TRS) where clozapine can be prescribed, but it causes severe
Externí odkaz:
https://doaj.org/article/08a702f79a394327949d86fd15521cac
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 755-764 (2024)
Leslie Citrome,1 Mariacristina Castelli,2 Masami Hasebe,3 Takaaki Terahara,3 Justin Faden,4 Marina Komaroff2 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Product Development, Noven Pharmaceuticals,
Externí odkaz:
https://doaj.org/article/18e35effb1b3429b9d101777d39862ac
Autor:
Ding, Qiuping a, b, 1, Li, Lingyu a, b, 1, Tong, Qiqi c, He, Hongjian d, ⁎, Gao, Bin e, ⁎, Xia, Ling a, ⁎
Publikováno v:
In Brain Research 15 October 2024 1841
Autor:
Sonny Teddy Lisal, Hawaidah Hawaidah, Dessy Natalia, Arifin Seweng, Yuyun Widaningsih, Erlyn Limoa, Saidah Syamsuddin
Publikováno v:
Healthcare in Low-resource Settings (2024)
The study aimed to determine the efficacy of risperidone on PANSS scores and Interleukin 6 (IL-6) levels in schizophrenia patients with confirmed COVID-19. The study type was analytical observational, with a prospective cohort design. The subjects in
Externí odkaz:
https://doaj.org/article/9bf3cc97d9574098b1c616c95a567a13
Autor:
Maria Staniek, Pawel Kapelski, Przemyslaw Zakowicz, Aleksandra Rajewska-Rager, Karolina Wasicka-Przewozna, Maria Skibinska
Publikováno v:
Brain Sciences, Vol 14, Iss 7, p 699 (2024)
(1) Background: Schizophrenia is a chronic and progressive neuropsychiatric illness. Apart from positive and negative symptoms, 98% of the population diagnosed with schizophrenia have impaired cognitive functioning, which significantly influences the
Externí odkaz:
https://doaj.org/article/804be8a9bc7b4d51a57b2d9418d47436
Autor:
Xinxing Fei, Jiyang Li, Shiqi Wang, Jianxiong Wang, Changmei Guo, Rizhi Qisha, Yaqian Gao, Yue Hu
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
ObjectiveSchizophrenia is a serious mental disease that brings not only serious burdens to patients and their families but also serious challenges to society. More research is needed to find better drugs to treat schizophrenia. This meta-analysis inv
Externí odkaz:
https://doaj.org/article/2a7f8177c5164f93bba392bd9cbe8b17
Autor:
Arij Yehya, Salma M. Khaled, Iris E. C. Sommer, Saba F. Elhag, Mohamed H. M. O. Hassan, Peter Woodruff, Majid Alabdalla
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Psychotic experiences are reported in the general population. The Questionnaire for Psychotic Experiences (QPE) was created to test the phenomenological features of these experiences and compare them with those reported in patient
Externí odkaz:
https://doaj.org/article/7d195aab5ddc4d20841b0a3403a68499
Autor:
Paramvir Singh, Yesh Chandra Singh, Abhinav Pandey, Chitrakshee Singh, Nirali Muchhala, Sagar Karia
Publikováno v:
Annals of Indian Psychiatry, Vol 7, Iss 3, Pp 203-206 (2023)
Background: Treatment-resistant schizophrenia (TRS) is one of the most disabling forms of schizophrenia. The Indian population being different in its sociodemographic factors, clinical profiles, and family structures, the experience of the efficacy o
Externí odkaz:
https://doaj.org/article/ee9d7b9e12be46f19aeca8feabdf4d55
Autor:
N Pramoda, V Avinash Turankar, Manish Namdeo Thakre, Sudhir Laludeo Mahajan, Sunil Mahakalkar, Ashwita Uday Shetty, Sandeep M Sasi
Publikováno v:
Annals of Indian Psychiatry, Vol 7, Iss 4, Pp 339-344 (2023)
Context: Schizophrenia is mostly treated with atypical antipsycotics, which may be required for lifetime. Olanzapine is commonly used in this condition, whereas levosulpiride is approved in India for the same. Knowing the effect of these drugs on psy
Externí odkaz:
https://doaj.org/article/d178615e6bdd44a9b02ce0681756b33e
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Literature explains participation limitations among people with schizophrenia through the context of metacognitive limitations, specifically in symptoms and in executive functions (EF). Research has shown mixed results regarding a
Externí odkaz:
https://doaj.org/article/1bcac97d946c4eb798de64c6de3cdf1b